UK MHRA Picks Pharmacovigilance For First AI Guideline
Companies Are Opting For Natural Language Processing To Speed Up Case Processing
Executive Summary
In the first of a two-part series of articles on the use of artificial intelligence in pharmacovigilance, the Pink Sheet reports on what factors the UK medicines inspectors consider crucial to demonstrate the effectiveness of such AI systems. The second article will discuss how the balance between the use of AI and human resources is likely to change over time.
You may also be interested in...
AI Changing The Skills Balance In Pharmacovigilance Teams
In the second segment of a two-part article on the use of artificial intelligence in pharmacovigilance, a senior UK regulator and representatives from the pharmaceutical industry discuss new skills that drug safety professionals must acquire as companies increasingly embrace AI tools.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.